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Abstract 
Purpose:  
Rotavirus is recognized as the most important agent of severe acute gastroenteritis in young 
children. In a two-year prospective survey, we investigated the epidemiology and clinical 
features of the viral and bacterial pathogens in children hospitalized for acute gastroenteritis.  
Methods:  
The study was performed in a Parisian teaching hospital from November 2001 to May 2004. 
Clinical data were prospectively collected to assess the gastroenteritis severity (20-point 
Vesikari severity score, the need for intravenous rehydration, duration of hospitalization). 
Stools were systematically tested for group A rotavirus, norovirus, astrovirus and adenovirus 
40/41, sapovirus and Aïchi virus and enteropathogenic bacteria. 
Results:  
457 children (mean age 15.9 months) were enrolled. Viruses were detected in 305 cases 
(66.7%) and bacteria in 31 cases (6.8%). Rotaviruses were the most frequent pathogen 
(48.8%) followed by noroviruses (8.3%) and adenoviruses, astroviruses, Aïchi viruses and 
sapoviruses respectively in 3.5%, 1.5%, 0.9% and 0.4%. Cases of rotavirus gastroenteritis 
were significantly more severe than those of norovirus with respect to the Vesikari score, 
duration of hospitalization and the need for intravenous rehydration.  
Conclusion:  
Rotaviruses were the most frequent and most severe cause in children hospitalized for acute 
gastroenteritis, noroviruses also account for a large number of cases in this population. 
  
Acute gastroenteritis (AGE) is one of the most common diseases in humans, and continues to 
be a cause of high morbidity and mortality in children worldwide. Children under 5 years of 
age are particularly prone, and it is calculated that, in this group, there are more than 700 
million cases of acute diarrhoea every year [1]. Worldwide estimates indicate a mean of 
between 3.5 and 7 episodes of diarrhoea during the first 2 years of life, and over 11 000 
deaths per day throughout the world, particularly in developing countries [2]. In developed 
countries, deaths from diarrhoea are less common, but AGE is a major cause of morbidity in 
childhood, leading to many hospitalizations and doctor’s visits [3-5].  
 
Much of the gastroenteritis in children is caused by viruses. Group A rotaviruses are the 
leading cause of severe acute gastroenteritis in infants and children throughout the world, 
causing an estimated 500,000 - 600,000 deaths each year. All children are infected by the age 
of 2-3 years and the first infection can usually be associated with acute diarrhoea, which can 
be severe. Other viral agents of AGE are enteric adenoviruses, caliciviruses and astroviruses. 
With the improvements in molecular methods of viral diagnosis over the past decade, the role 
of noroviruses in the etiology of childhood diarrhoea is increasingly recognized. In contrast, 
the role of Aichi viruses, which belong to the picornavirus family, is not well known [6, 7].  
 
To date, there are few data available about the enteric viruses and bacteria in circulation in 
France. The prevalence and diversity of the four major viruses (rotaviruses, caliciviruses, 
astroviruses and adenoviruses) are documented for gastroenteritis in children consulting a 
physician or a hospital emergency service [8-10]. In contrast, their role in community-
acquired severe AGE requiring hospitalization have rarely been investigated [11]. The first 
study of hospitalized gastroenteritis conducted in Saint Vincent de Paul children’s hospital 
(Paris) from January 1997 to December 2000 reported that 50.89% of 725 children 
hospitalized for AGE were infected with rotavirus. The role of other viral pathogens was not 
investigated [12].  
 
We have conducted a prospective study to determine the viral and bacterial etiology of AGE 
in children hospitalized for AGE. In collaboration with the National Reference Center (NRC) 
of enteric viruses based in Dijon, we systematically searched for viral pathogens (rotavirus, 
norovirus, sapovirus, astrovirus, enteric adenovirus and Aichi virus) using sensitive molecular 
methods. Bacterial pathogens (Salmonella, Shigella and Camplylobacter spp.) were also 
systematically screened for. We investigated the clinical pattern of the disease in these 
children and the severity of the episodes of AGE. This study provides precise data on the 
frequency and the severity of bacterial and viral pathogens among children hospitalized for 
AGE in a Parisian paediatric hospital during a 2-year period.  
 
Patients and methods. 
 
Population, clinical definitions and specimen collection.  
 
The study was carried out in the Parisian teaching hospital Cochin- Saint Vincent de Paul, 
which is situated at the south of Paris and provides easy access to appropriate medical care. 
At this hospital, there are a mean of 23,000 consultations for all causes in children every year; 
15 to 20 % of the consultations for diarrhoea lead to hospitalization [12]. 
After its approval by the Ethics Committee of the Cochin-Paris V Faculty of medicine, the 
study was prospectively performed between November 2001 and May 2004 and included all 
children between 0 months and 15 years of age hospitalized with acute diarrhoea. Acute 
diarrhoea was defined as at least 3 looser-than normal stools within a 24-h period. All 
admissions to the hospital were based on clinical examinations at the request of the hospital 
emergency team. Patients with chronic diarrhoea (> 10 days) were excluded. For each child, 
clinical data including, age, sex and admission date were prospectively collected at inclusion. 
Each episode was graded using the 20-point severity score scale [13, 14]. Furthermore, the 
occurrence of bloody diarrhoea, the use of intravenous rehydration and the length of 
hospitalization were documented. Stool samples were systematically collected to screen for 
etiologic agents of diarrhoea. Bacteria (Salmonella, Shigella and Campylobacter spp.) were 
detected by routine cultivation in the Bacteriology Laboratory of the Saint Vincent de Paul 
Hospital. After collection, the samples were stored frozen (- 20°C) at the Virology 
Laboratory. The stools were sent together to the enteric viruses NRC (Dijon), for viral 
investigation. 
 
Laboratory methods. 
 
The presence of pathogenic bacteria was determined by routine culture assays on selective 
media. Stool samples were screened for the presence of group A rotaviruses, adenovirus
 
types 
40 and 41 and astroviruses by commercial enzyme immunoassay (EIA) kits (respectively: 
Biomérieux, France; Oxoïd Ltd, UK; Meridian Diagnostics Inc, USA). All positive samples 
were confirmed and characterized by molecular biology methods (PCR or RT-PCR). 
Noroviruses, sapoviruses and Aichi virus were detected by RT-PCR.
  
Nucleic acids were extracted
 
from 20% stool suspensions in phosphate-buffered saline with
 
a 
QIA Amp viral RNA kit (Qiagen, Hilden, Germany). The Rotavirus RT-PCR used the primer 
sets Beg9/End9 [15] and Con2/Con3 [16], The astrovirus RT-PCR used the primers Mon 244 
and Mon 245 [17] and the adenovirus PCR used the primers Hex1DEG/Hex2DEG [18]. The 
norovirus and sapovirus RT-PCR used primer sets in separate reactions. The primer sets 
SR80/NVP110 [19] and JV12/JV13 [20] were used to amplify a fragment of the RNA 
polymerase gene of sapoviruses and noroviruses, respectively. The primer sets 
G1SKF/G1SKR and G2SKF/G2SKR [21] were used to amplify a fragment of the capsid gene 
of genogroup I and II noroviruses, respectively. The Aichi virus RT-PCR used the primers 
Ai6261/6779 targeting the RNA polymerase gene [22]. 
Genotyping of norovirus, sapovirus, astrovirus and Aichi virus was performed by direct 
sequencing of the PCR products using the ABI Prism Big Dye Terminator Cycle Sequencing 
Ready Reaction Kit and an automated sequencer (model 373A DNA sequencing system, 
Applied Biosystems). 
 
Statistical methods. 
Statistical analysis was performed with the Mann-Whitney U test, which was used to compare 
the medians of clinical symptoms scores in associated rotavirus and norovirus cases. For 
comparison of proportions, chi-square or Fisher’s exact test was used. All tests were two-
tailed and considered significant when the P value was ≤ 0.05. 
 
Results 
 
Study population and general screening.  
A total of 552 children were hospitalized for gastroenteritis between November 2001 and 
May 2004. Clinical data and stool samples were obtained from 457 (82.8%) children. The 
mean age of these children was 15.9 months (standard deviation, 22.13; range, 0.2 -156 
months) and the median was 9.25 months. The sex ratio was 1.26. The mean Vesikari score 
was 11.7 (standard deviation, 3.16; range, 4-19). Among the 95 sets of data rejected in this 
study, 13 were rejected for the lack of clinical data and 82 for the absence of a faecal sample. 
Comparison of the data of patients at the time of enrolment showed that there was no 
significant difference between the data (mean age, sex ratio and Vesikari score) of included 
and excluded cases (p> 0.05, Mann-Whitney U-test), (data not shown). 
 
Laboratory investigations detected at least one pathogen (virus and/or bacteria) in 330 stool 
samples (72.2%) of the 457. Viral pathogens were detected in 305 (66.7%) samples, and 
bacterial pathogens in 31 (6.8%) samples. 
Among the viruses, group A rotaviruses were detected in 240 samples (223 in single 
infections, 17 in mixed infection) and the most prevalent G type were G1 (114 isolates, 
47.5%), G4 (38 isolates, 15.8%), G3 (38 isolates, 15.8%), G9 (6 isolates, 2.5%) and G2 (6 
isolates, 2.5%). The P[8] type was by far the most frequent accounting for 233 rotaviruses 
strains (97 % of rotaviruses strains). The second most frequent group of viruses was norovirus 
with 55 isolates (38 in single infections and 17 in mixed infections). Molecular 
characterization showed that genogroup II (GGII) strains were clearly predominant with 50 
isolates (90.9%) including 28 GGII.4 (50.9%), 18 GGIIb (32.7%), 3 GGII.2 (5.5%) and 1 
GGII.7 (1.8%). The remaining 5 noroviruses belonged to the GGI (genotypes 1, 2, 4 and 6). 
The other viruses were less frequency detected: enteric adenoviruses were detected in 16 
samples, (3.5%), astrovirus in 7 (1.5%), Aichi in 4 samples (0.9%) and sapovirus in 2 samples 
(0.4%). Bacterial pathogens were 13 Campylobacter, 14 non typhi Salmonella, 5 Shigella. 
 
Single pathogen infections were responsible for 307 cases of gastroenteritis, most of which 
were viral agents (283 samples versus 25 samples (24: 1 bacterium; 1: 2 bacteria) for 
bacteria). Among these, rotaviruses were responsible for 223 cases (48.8%) and noroviruses 
for 38 cases (8.3%). The other enteric viruses were adenovirus type 40/41, astrovirus, Aïchi 
virus and sapovirus respectively in 16, 3, 2 and 1 cases. Single bacterial pathogens were found 
in 24 cases (12 Campylobacter, 9 non typhi Salmonella sp., 3 Shigella). 
 
Mixed infections were detected in 23 samples and mainly involved combinations of viruses 
(16 samples) especially rotavirus and norovirus. Dual infections with rotavirus and norovirus 
were detected in 10 samples, with norovirus and astrovirus or sapovirus in 1 sample, with 
rotavirus and astrovirus or Aïchi virus in 1 sample. Triple infections with norovirus, rotavirus 
and astrovirus were detected in 2 samples. Mixed infections involving viruses and bacteria 
were detected in 6 samples: non typhi Salmonella was associated with rotavirus in 2 samples, 
with norovirus in 1 sample and with norovirus-rotavirus in 1 sample; Campylobacter was 
associated with norovirus and Shigella with Aïchi virus in 1 sample. There was only one dual 
bacterial infection, which associated Salmonella and Shigella (Table 1). 
 
Monthly distribution. 
The peak of the gastroenteritis epidemic was due to rotavirus and was observed during the 
winter months, the highest peak occurred in January. Interestingly, a second lower peak of 
rotavirus incidence was observed in September. Rotaviruses continued to be detected in the 
interepidemic season but, during these 2 years of surveillance, rotaviruses were not detected 
in June 
Norovirus AGE have a seasonal pattern similar to that of rotavirus AGE with a main peak 
observed in January and a second peak in September (Figure 1). No consistent seasonal 
pattern was observed for enteric adenovirus, astrovirus and bacterial AGE. 
 
Etiology of hospitalized AGE in relation to age of the children. 
The proportion of the pathogens detected among children in different age groups is presented 
in Table 1.  
Most hospitalizations for AGE were reported in children less than 2 years of age (385 
children, 84.2%). In these children, 267 (69.3%) had a viral etiology: rotavirus and norovirus 
were detected in 210 (54.5%) and 47 (12.2%) stool samples, respectively; a single bacterial 
etiology was identified in 14 stool samples (3.6%) and mixed bacterial and viral infections in 
5 stool samples (1.3%). In 99 cases of AGE (25.7%), no acknowledged pathogen was 
identified. 
One hundred and seventy-seven hospitalized children (38.7%) were less than 6 months of age. 
In these children, 97 (54.8%) had a viral etiology: rotavirus and norovirus were detected in 77 
(42.4%) and 15 (8.5%) stool samples respectively. Single bacterial etiology was identified in 
8 stool samples (4.5%) and mixed bacterial and viral infections in 2 stool samples (1.1%). In 
67 cases of AGE (37.8%), no acknowledged pathogen was identified.  
 
Clinical severity criteria in children hospitalized for rotavirus or norovirus AGE. 
The clinical severity of the disease was analyzed in children infected by a single virus 
(rotavirus or norovirus). The 223 children infected with rotavirus and the 38 children infected 
with norovirus were similar in terms of age and sex ratio (p> 0.05, Mann-Whitney U-test). 
The mean age was 13.65 months (median: 9 months) for rotavirus infections versus 14.9 
months (median: 9.5 months) for norovirus infections. The sex ratio was 1.27 for rotavirus 
infections versus 1.23 for norovirus infections. 
 
The correlation between the severity of the AGE (severity score, intravenous rehydration, 
length of hospitalization) and the virus (rotavirus and norovirus) is reported in table 2.  
Rotavirus AGE were more severe in infants above 6 months than in infants from 0 to 6 
months (p<0.0001). Rotavirus AGE were significantly more severe than norovirus AGE with 
respect to the Vesikari score (12.6 versus 10.47, p<0.001), the duration of the hospitalizations 
(3.2 days versus 1.85, p<0.001) and the requirement for intravenous rehydration (77.13% 
versus 55.26%, p= 0.005). This contrast was more marked in children above 6 months 
(p<0.007 for severity score and p<0.001 for the length of hospitalization and p=0.03 for the 
need for intravenous rehydration).  
These differences in severity according to age were not observed in norovirus gastroenteritis. 
DISCUSSION 
This is the first prospective study to provide data for cause-specific hospitalizations due to 
community acquired gastroenteritis in children in France. This study was conducted from 
November 2001 to May 2004 in a Parisian paediatric hospital, but these results are still 
relevant today. The management of acute gastroenteritis is currently the same with use of an 
oral rehydration solution and/or intravenous fluid replacement; the trends of hospitalization 
should continue to show the same pattern. The two rotavirus vaccines (RotaTeq and Rotarix) 
were licensed in France in 2006, but rotavirus vaccination is not included in the French 
official recommendations for childhood immunizations, and vaccine coverage is still very 
low, less than 10 percent. 
Our results show that group A rotavirus caused more than 50 % of the total hospitalizations 
for gastroenteritis per year in a paediatric unit in Paris (France) and was the leading cause of 
severe diarrhoea in young children. In addition, they highlight the role of norovirus in France 
as the second viral etiologic agent causing 12% of hospitalizations for AGE in children. In 
contrast, the other enteric viruses including adenovirus type 40 and 41, astrovirus, sapovirus 
and Aichi virus were a minor cause of hospitalization for childhood gastroenteritis. 
Altogether, our results show that viruses are by far the most frequent etiology in children 
hospitalized for gastroenteritis (66.7%), whereas a bacterial etiology was found in 6.8% of 
cases, and the etiology of 27.8% of the AGE was not elucidated. 
Previous studies underlined the importance of viruses in children hospitalized for 
gastroenteritis especially in developed countries [23, 24]. However, few studies have 
investigated prospectively the relative contributions of the different enteric viruses and 
bacteria in children admitted to hospital for gastroenteritis in developed countries. In 
accordance with our results, studies conducted in other developed countries in hospitalized 
children found a large predominance of viruses (56 to 70%) versus bacteria (4 to 17%) [25, 
26]. A large retrospective study conducted in Australia found the same ratio between viral and 
bacterial etiologies in children [27]. In contradiction with these studies, Boga et al [28] in a 
study conducted in Asturias found bacteria and viruses with a similar frequency, 
Campylobacter jejuni and Salmonella spp were respectively the second and third main cause 
of gastroenteritis in children. Among the bacterial etiologies, we also found a large 
predominance of C. jejuni and Salmonella spp, but, on the whole, bacteria were a minor cause 
of hospitalization for diarrhoea in children. 
Among the viruses, rotaviruses were by far the main cause of gastroenteritis in hospitalized 
children, far ahead of noroviruses, which were found in 8-15% of children hospitalized for 
gastroenteritis [8, 25, 29-31]. These studies and our results contrast with other sentinel studies 
conducted by physicians in the general population [5, 7, 10], in which the incidence of 
norovirus ranged from 10 to 20%. This is close to and in some cases even higher than the 
incidence of rotavirus infections [10]. One possible explanation of the relatively higher 
incidence of norovirus is that these sentinel studies highlight the diagnosis of mild infections, 
whereas more severe cases of gastroenteritis are admitted to the emergency department of the 
hospital. 
Sequence typing of the rotavirus strains showed that the main type was G1;P[8] (47.5%) 
followed by the two other conventional types: G3;P[8] (15.8%) and G4;P[8] (15.8%) whereas 
the G9;P[8] type was seldom detected (2.5%). This pattern of genotype distribution with the 
low prevalence of the G9 type was close to that reported in our previous works since 1995 [8, 
10], but considerably different from that we reported during the 2004/2005 season following 
the present study. In this latter season, G9;P[8] emerged as by far the major genotype (54.7%) 
whereas G1;P[8] was very rarely detected [32].  
Among noroviruses, there was a clear predominance of genogroup II, and especially the 
GGII.4 genotype, which is currently reported in adult gastroenteritis outbreaks [33]. 
Norovirus genotype GII.4 has also been reported as the main norovirus genotype in sporadic 
cases of gastroenteritis in children [9, 25, 28]. In accordance with these previous reports, our 
results show that norovirus GGII.4 was predominantly detected in the faeces of children. 
GGII.4 norovirus was observed throughout the study with a peak during the winter of 
2002/2003. It is important to note that this peak corresponded to an increase in gastroenteritis 
outbreaks throughout Europe caused by a new variant (HU/NoV/Farmington Hill/2002/USA, 
accession number AY502023)[34, 35]. The second most frequent norovirus genotype found 
in this study was GGII.b. Several studies have reported this genotype as a cause of sporadic 
and outbreak cases of gastroenteritits in children, and some of these studies suggested that 
GGIIb was closely associated with infections in children [36-40]. In this study, the highest 
rates of GGIIb detection were observed in January-February 2002 and the fall and winter of 
2003-2004. These periods coincide with GGIIb adult outbreaks in France [41]. So, the rate of 
detection of GGIIb and GGII.4 norovirus strains identified in children are similar to those 
circulating in the adult population in the same period. These results and more recent data (data 
not shown) do not support the hypothesis that one of these strains could play a predominant 
role in children. 
The severity of norovirus and rotavirus gastroenteritis excluded mixed infections and was 
evaluated on three criteria, the severity score defined by Vesikari [13], the need for 
intravenous rehydration and the length of the hospitalization. In the population of children 
studied, norovirus infections were significantly less severe than rotavirus infections. The 
literature concerning symptom severity in norovirus and rotavirus gastroenteritis is 
heterogeneous [42]. A number of previous studies found lower levels of disease severity in 
norovirus than in rotavirus gastroenteritis, and most of these were carried out in developed 
countries [7, 43-47]. In contrast, other studies found no significant differences between the 
severity of rotavirus and norovirus infections [48-51]. One such study was conducted by us in 
Tunisia, and we attributed the severity of the norovirus infection to a lack of medical care at 
home and the delay to hospitalization for children infected with norovirus. This could also be 
the case for the studies conducted in countries with poor sanitation and hygiene. 
 
In conclusion, these results highlight the main role of rotavirus in hospitalized gastroenteritis 
among French children less than 2 years of age. During the study until the end of the 2003-
2004 winter season the G1;P[8] genotype was widespread while G9:P[8] remained rare. A 
majority of severe rotavirus gastroenteritis requiring hospitalization may be prevented by the 
widespread use of rotavirus vaccines [52-54]. Noroviruses are the second leading causative 
agent of gastroenteritis in hospitalized young children and such infections are less severe than 
those caused by rotavirus. The norovirus genotype pattern in children shows a clear 
predominance of genotype GII.4 followed by genotype GGIIb. This pattern reflects the 
norovirus genotypes in circulation within the population rather than a predominance of 
particular genotypes in children. 
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Table 1: Etiology of gastroenteritis in 457 hospitalized children in relation to age. 
 
 Age (months) Total 
 0-6 >6-12 >12-24 >24-60 >60-180  
Rotavirus 77 
(43.5%) 
63 
(59.4%) 
59 (57.8%) 22 (44.9%) 4 (17.4%) 223 
(48.8%) 
Norovirus 15 (8.5%) 10 (9.4%) 8 (7.8%) 3 (6.1%) 2 (8.7%) 38 (8.3%) 
Adenovirus 6 5 5 0 0 16 (3.50) 
Astrovirus 1 2  0 0 0 3 
Aïchivirus 0 0 1  0  1  2 
Sapovirus 0 0 1 0 0 1 
Bacteria 8 2
a
 4 6 5 25
a
 
(5.4%) 
Virus + 
Bacteria 
2
b ; c
 0 3
d ; e
 1
f
 0 6 
Virus + virus 3
 g ; h ; i
 9
j ; k ; l ; m 
 4 0 0 16 (3.5%) 
NPI*  67 (37.8 
%) 
15 (14.1 
%) 
17 (16.7 
%) 
17 (34.7 
%) 
11 (47.8 
%) 
127 (27.8 
%) 
Total 177 
(38.7%) 
106 
(23.2%) 
102 
(22.32%) 
49 
(10.72%) 
23 
(5.03%) 
457 
 
Values are numbers of cases, with percentages in parentheses. 
* NPI: No acknowledged enteric pathogens. 
a : 1 Salmonella  + shigella  
b : 1 Salmonella  + norovirus  
c : 1 campylobacter  + norovirus  
d : 1 Salmonella  + norovirus + rotavirus  
e : 2 Salmonella  + rotavirus  
f : 1 Shigella  + Aichi virus  
g : 1 norovirus + astrovirus  
h : 1 norovirus + rotavirus 
i : 1 norovirus + rotavirus 
j : 2 norovirus + rotavirus  + astrovirus  
k : 1 rotavirus  + Aichi virus  
l : 1 rotavirus  + astrovirus  
m : 5 norovirus + rotavirus 
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Table 2: Clinical features according the etiologic agent (rotavirus or norovirus, mixed 
infections excluded) related to the age of the children with gastroenteritis. 
 
 
Age 0-6 months (177) 6-24 months (208)  > 24 months (72) Total (261) 
 
Rotavirus 
(75) 
Norovirus 
(15) 
p value  
Rotavirus 
(122) 
Norovirus 
(18) 
p value  
Rotavirus 
(26) 
Norovirus 
(5) 
p value  
Rotavirus 
(223) 
Norovirus 
(38) 
p value 
Severity score, 1-20 
points: mean value 
(+/-sd) 
11.1
a
 
(+/-2.89) 
9.93
 b
 
(+/-2.46) 
NS 
13.48
 a
 
(+/-2.54) 
11.39
 b
 
(+/-3.05) 
p<0.002 
12.88
 a
 
(+/-2.94) 
8,8
 b
 
(+/-2.28) 
p=0.007 
12.6 
(2.92) 
10.47 
(2.83) 
p< 0.001 
Length of 
hospitalization in 
days (+/-sd) 
3.26  
(+/-1.84) 
2.17 
(+/-1.06) 
p=0.0293 
2.90  
(+/-1.39) 
1.78 
(+/-1.06) 
p=0.0013 
2,85 
(+/-1.26) 
1,2 
(+/-0.45) 
p=0.0078 
3.02 
(1.54) 
1.85 
(1.03) 
p< 0.001 
Intravenous 
rehydration (%) 
40 
(53.3%) 
5 
(33.33%) 
NS 
107 
(87.7%) 
12 
(66.67%) 
p=0.031 
25 
(96.1%) 
4 
(80%) 
NS 
172 
(77.13%) 
21 
(55.26%) 
p= 0.005 
Bloody stools (%) 0 0  
3 
(2.46%) 
2 
(11.11%) 
 
1 
(3.8%) 
0 
(0%) 
 
4 
(1.79%) 
2 
(5.26 %) 
NS 
 
NS= Not significant 
a) Rotavirus severity score: 0-6 months versus 6-24 months (p<0.0001) or >24 months 
(p=0.008). 
b) Norovirus severity score: p not significant for all age groups.  
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Figure 1: Monthly distribution of viruses in children hospitalized for gastroenteritis (January 
2002- May 2004) 
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